Company research
Core Laboratories Inc. /DE/
CIK 1958086Updated Sep 25, 2026
SecurityCLB · NYSE · equity
Name history
Core Laboratories Luxembourg S.A. · through Feb 28, 2023
CLB price & chart
Loading TradingView…
NYSE:CLB on TradingView ↗In the news
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
4 filing
4 filing
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 584,010,000Source | 590,406,000Source | 586,395,000Source | 578,354,000Source |
| Property, Plant and Equipment, NetUSD | 99,447,000Source | 97,063,000Source | 99,626,000Source | 105,028,000Source |
| GoodwillUSD | 105,789,000Source | 99,445,000Source | 99,445,000Source | 99,445,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 7,118,000Source | 6,403,000Source | 6,926,000Source | 7,483,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 22,702,000Source | 19,157,000Source | 15,120,000Source | 15,428,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 113,528,000Source | 111,761,000Source | 109,352,000Source | 106,913,000Source |
| Inventory, NetUSD | 54,496,000Source | 59,402,000Source | 71,702,000Source | 60,445,000Source |
| Assets, CurrentUSD | 214,665,000Source | 226,606,000Source | 223,136,000Source | 211,702,000Source |
| Operating Lease, Right-of-Use AssetUSD | 54,346,000Source | 56,488,000Source | 53,842,000Source | 52,379,000Source |
| Other Assets, NoncurrentUSD | 35,264,000Source | 34,788,000Source | 34,219,000Source | 33,747,000Source |
| LIABILITIES AND EQUITY | ||||
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 470,000Source | 470,000Source | 469,000Source | 1,194,000Source |
| Retained Earnings (Accumulated Deficit)USD | 172,662,000Source | 150,280,000Source | 120,756,000Source | 85,949,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -5,806,000Source | -5,769,000Source | -4,972,000Source | -3,777,000Source |
| Stockholders' Equity Attributable to ParentUSD | 265,986,000Source | 251,991,000Source | 224,815,000Source | 184,258,000Source |
| Additional Paid in Capital, Common StockUSD | 110,245,000Source | 109,547,000Source | 110,011,000Source | 102,254,000Source |
| Liabilities and EquityUSD | 584,010,000Source | 590,406,000Source | 586,395,000Source | 578,354,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 106,015,000Source | 97,586,000Source | 88,097,000Source | 103,135,000Source |
| Operating Lease, Liability, CurrentUSD | 11,456,000Source | 10,690,000Source | 10,175,000Source | 11,699,000Source |
| Accounts Payable, CurrentUSD | 37,275,000Source | 34,549,000Source | 33,506,000Source | 45,847,000Source |
| Operating Lease, Liability, NoncurrentUSD | 42,309,000Source | 43,343,000Source | 42,076,000Source | 38,305,000Source |
| Deferred Income Tax Liabilities, NetUSD | 7,995,000Source | 13,783,000Source | 12,697,000Source | 22,877,000Source |
| Other Liabilities, NoncurrentUSD | 15,847,000Source | 20,732,000Source | 20,040,000Source | 20,883,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 6,222,000Source | 5,745,000Source | 4,992,000Source | 4,696,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 16,843,000Source | 15,859,000Source | 15,196,000Source | 31,757,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 110,255,000Source | 126,111,000Source | 163,134,000Source | 172,386,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 30,391,000Source | 32,153,000Source | 37,025,000Source | 19,658,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 14,649,000Source | 14,953,000Source | 15,784,000Source | 17,161,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 7,137,000Source | 3,755,000Source | 13,971,000Source | 7,756,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 4,953,000Source | 3,612,000Source | 2,618,000Source | 10,078,000Source |
| Increase (Decrease) in InventoriesUSD | -2,644,000Source | -9,367,000Source | 12,976,000Source | 14,860,000Source |
| Increase (Decrease) in Accounts PayableUSD | 477,000Source | 519,000Source | -12,878,000Source | 15,374,000Source |
| Deferred Income Tax Expense (Benefit)USD | 1,395,000Source | 620,000Source | -11,062,000Source | -657,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 37,031,000Source | 56,388,000Source | 24,789,000Source | 24,956,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 1,237,000Source | — | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -2,231,000Source | -6,394,000Source | -6,652,000Source | -3,856,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 11,209,000Source | 13,028,000Source | 10,579,000Source | 10,216,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 12,426,000Source | 5,306,000Source | 2,202,000Source | 3,903,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -31,255,000Source | -45,957,000Source | -18,445,000Source | -23,375,000Source |
| Payments of Ordinary Dividends, Common StockUSD | 1,869,000Source | 1,876,000Source | 1,868,000Source | 1,853,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -254,000Source | 0Source | -54,000Source | -2,000Source |
| Repayments of Long-term DebtUSD | 63,000,000Source | 82,000,000Source | 211,000,000Source | 131,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 22,702,000Source | 19,157,000Source | 15,120,000Source | 15,428,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 8,183,000Source | 10,859,000Source | 11,198,000Source | 9,300,000Source |
| Income Taxes Paid, NetUSD | 18,735,000Source | — | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 359,000Source | 504,000Source | 490,000Source | 685,000Source |
| DepreciationUSD | 14,290,000Source | 14,449,000Source | 15,294,000Source | 16,476,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -745,000Source | -1,197,000Source | 176,000Source | 229,000Source |
| Gain (Loss) on Disposition of AssetsUSD | 813,000Source | 1,779,000Source | 200,000Source | 1,068,000Source |
| Gain (Loss) on Disposition of BusinessUSD | — | — | 0Source | 0Source |
| Gain (Loss) on Sale of DerivativesUSD | 300,000Source | 100,000Source | 900,000Source | — |
| General and Administrative ExpenseUSD | 45,430,000Source | 39,770,000Source | — | — |
| GoodwillUSD | 105,789,000Source | 99,445,000Source | 99,445,000Source | 99,445,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | 0Source | 0Source | 0Source | 0Source |
| Income (Loss) from Equity Method InvestmentsUSD | 45,896,000Source | 46,187,000Source | 41,210,000Source | 29,954,000Source |
| Income Tax Expense (Benefit)USD | 15,505,000Source | 14,034,000Source | -4,185,000Source | 10,296,000Source |
| Inventory Write-downUSD | 2,262,000Source | 2,933,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | 29,669,000Source | 31,400,000Source | 36,675,000Source | 19,453,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 722,000Source | 753,000Source | 350,000Source | 205,000Source |
| Operating Lease, Impairment LossUSD | — | — | 1,100,000Source | — |
| Other Nonoperating Income (Expense)USD | 7,614,000Source | 9,953,000Source | -850,000Source | -722,000Source |
| Other Operating Income (Expense), NetUSD | 7,614,000Source | 9,953,000Source | 850,000Source | 722,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | 0Source | 0Source |
| Proceeds from Issuance of Long-term DebtUSD | 48,000,000Source | 44,000,000Source | 202,000,000Source | 116,000,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 526,520,000Source | 523,848,000Source | 509,790,000Source | 489,735,000Source |
| Cost of RevenueUSD | 417,587,000Source | 420,522,000Source | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Operating Income (Loss)USD | 56,468,000Source | 58,556,000Source | 54,640,000Source | 41,524,000Source |
| Other Nonoperating Income (Expense)USD | 7,614,000Source | 9,953,000Source | -850,000Source | -722,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 45,896,000Source | 46,187,000Source | 41,210,000Source | 29,954,000Source |
| Income Tax Expense (Benefit)USD | 15,505,000Source | 14,034,000Source | -4,185,000Source | 10,296,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 722,000Source | 753,000Source | 350,000Source | 205,000Source |
| Net Income (Loss) Attributable to ParentUSD | 29,669,000Source | 31,400,000Source | 36,675,000Source | 19,453,000Source |
| Earnings Per Share, BasicUSD per share | 0.64Source | 0.67Source | 0.79Source | 0.42Source |
| Earnings Per Share, DilutedUSD per share | 0.63Source | 0.66Source | 0.77Source | 0.42Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 46,427,000Source | 46,897,000Source | 46,683,000Source | 46,334,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 47,028,000Source | 47,685,000Source | 47,523,000Source | 46,813,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 359,000Source | 504,000Source | 490,000Source | 685,000Source |
| Current Income Tax Expense (Benefit)USD | 14,110,000Source | 13,414,000Source | 15,247,000Source | 10,953,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -745,000Source | -1,197,000Source | 176,000Source | 229,000Source |
| General and Administrative ExpenseUSD | 45,430,000Source | 39,770,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -3,247,000Source | -11,045,000Source | 3,907,000Source | -4,099,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | 0.65Source | 0.69Source | 0.79Source | 0.42Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | 0.65Source | 0.67Source | 0.78Source | 0.42Source |
| Income (Loss) from Equity Method InvestmentsUSD | 45,896,000Source | 46,187,000Source | 41,210,000Source | 29,954,000Source |
| Interest ExpenseUSD | 10,572,000Source | 12,369,000Source | 13,430,000Source | 11,570,000Source |
| Other Operating Income (Expense), NetUSD | 7,614,000Source | 9,953,000Source | 850,000Source | 722,000Source |
Filing attachments
clb-ex99_1.htm · 8-K · 2026-07-29
EX-99.1 2 clb-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE CORE LAB REPORTS SECOND QUARTER 2026 RESULTS: • REVENUE OF $124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR • OPERATING INCOME OF $9.2 MILLION; EX-ITEMS, $9.4 MILLION, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR • GAAP EARNINGS PER SHARE OF $0.13; EPS EX-ITEMS OF $0.11, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR • FREE CASH FLOW OF $3.1 MILLION • COMPANY REPURCHASED 214,712 SHARES OF COM…
Read attachment ↗clb-ex99_1.htm · 8-K · 2026-04-29
EX-99.1 2 clb-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE CORE LAB REPORTS FIRST QUARTER 2026 RESULTS: • REVENUE OF $121.8 MILLION, DOWN 12% SEQUENTIALLY AND FLAT YEAR-OVER-YEAR • OPERATING INCOME OF $1.9 MILLION; EX-ITEMS, $6.6 MILLION, DOWN 58% SEQUENTIALLY AND 44% YEAR-OVER-YEAR • GAAP LOSS PER SHARE OF $0.02; EPS EX-ITEMS OF $0.06, DOWN 72% SEQUENTIALLY AND 58% YEAR-OVER-YEAR • FREE CASH FLOW OF $0.5 MILLION • NET DEBT INCREASED BY $3.9 MILLION; LEVERAGE RATIO A…
Read attachment ↗clb-ex99_1.htm · 8-K · 2026-03-23
EX-99.1 2 clb-ex99_1.htm EX-99.1 EX-99.1 FOR IMMEDIATE RELEASE CORE LAB ANNOUNCES: • IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE • FIRST QUARTER 2026 EARNINGS WEBCAST AT 7:30 A.M. CDT / 8:30 A.M. EDT ON APRIL 30, 2026 HOUSTON (March 23, 2026) - Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") continues to evaluate and monitor the evolving geopolitical conflict in the Middle East and its effect on the Company’s first quarter 2026 financial…
Read attachment ↗